LFMDP:NSD-LifeMD Inc Preferred Series A (USD)

PREFERRED STOCK | Health Information Services |

Last Closing

USD 22.15

Change

-0.25 (-1.12)%

Market Cap

N/A

Volume

2.70K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.48 (+0.71%)

USD 10.78B
DOCS Doximity Inc

+0.46 (+1.06%)

USD 7.70B
WEAV Weave Communications Inc

+0.47 (+3.75%)

USD 0.89B
AMWL American Well Corp

+0.29 (+3.20%)

USD 0.14B
MPLN MultiPlan Corporation

+1.02 (+12.78%)

USD 0.12B
OWLT Owlet Inc

-0.07 (-1.53%)

USD 0.07B
STRM Streamline Health Solutions In..

+2.37 (+1,185.64%)

USD 0.01B
PHR Phreesia Inc

+0.12 (+0.54%)

N/A
VEEV Veeva Systems Inc Class A

+0.14 (+0.07%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing LFMDP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.06% 92% A 69% C-
Dividend Return 11.53% 100% F 98% N/A
Total Return 26.59% 92% A 85% B
Trailing 12 Months  
Capital Gain 18.51% 75% C 50% F
Dividend Return 11.87% 100% F 95% A
Total Return 30.38% 83% B 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.99% N/A N/A 65% D
Dividend Return 17.02% N/A N/A 74% C
Total Return 8.03% N/A N/A 94% A
Risk Return Profile  
Volatility (Standard Deviation) 29.25% N/A N/A 63% D
Risk Adjusted Return 58.18% N/A N/A 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector